6
Participants
Start Date
December 31, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Panitumumab and bortezomib
"Panitumumab 6 mg/kg IV over 60 minutes on Day -14 (first cycle only), then Day 1 and 15 of each 28-day cycle.~Bortezomib will be administered in escalating doses until the maximum tolerated dose is determined and then at the maximum tolerated dose as an IV bolus injection over 3-5 seconds on Day 1, 8, and 15 of each 28-day cycle."
Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
Georgetown University
OTHER